Co-Authors
This is a "connection" page, showing publications co-authored by Sophie Caillard and Ilies Benotmane.
Connection Strength
7.540
-
Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19. Am J Transplant. 2021 11; 21(11):3808-3810.
Score: 0.958
-
Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses. JAMA. 2021 Jul 23.
Score: 0.958
-
Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine. Kidney Int. 2021 06; 99(6):1498-1500.
Score: 0.941
-
Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients. Kidney Int. 2021 06; 99(6):1487-1489.
Score: 0.936
-
Persistence of SARS-CoV-2 antibodies in kidney transplant recipients. Am J Transplant. 2021 06; 21(6):2307-2310.
Score: 0.924
-
Biomarkers of Cytokine Release Syndrome Predict Disease Severity and Mortality From COVID-19 in Kidney Transplant Recipients. Transplantation. 2021 01 01; 105(1):158-169.
Score: 0.922
-
SARS-Cov-2 Seroprevalence in a French Kidney Transplant Center Located Within a "High-risk" Zone. Transplantation. 2021 10 01; 105(10):2165-2169.
Score: 0.243
-
Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19. Am J Transplant. 2021 08; 21(8):2871-2875.
Score: 0.238
-
COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report. J Nephrol. 2021 08; 34(4):1045-1048.
Score: 0.236
-
Is COVID-19 infection more severe in kidney transplant recipients? Am J Transplant. 2021 03; 21(3):1295-1303.
Score: 0.232
-
SARS-CoV-2 viral dynamics in immunocompromised patients. Am J Transplant. 2021 04; 21(4):1667-1669.
Score: 0.228
-
In-depth virological assessment of kidney transplant recipients with COVID-19. Am J Transplant. 2020 11; 20(11):3162-3172.
Score: 0.226
-
Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab. Kidney Int. 2020 08; 98(2):508-509.
Score: 0.221
-
First case of COVID-19 in a kidney transplant recipient treated with belatacept. Am J Transplant. 2020 Jul; 20(7):1944-1946.
Score: 0.220
-
Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients. J Infect Dis. 2021 02 24; 223(4):600-609.
Score: 0.058